Human arthroplasty derived macrophages differentiate into osteoclastic bone resorbing cells

Area of Science:

• Biomedical Engineering
• Immunology
• Orthopedic Surgery

Background:

• Aseptic loosening is a major cause of artificial joint failure, characterized by macrophage infiltration in response to biomaterial wear particles.
• The precise role of these macrophages in periprosthetic bone loss remains incompletely understood.

Purpose of the Study:

• To investigate whether macrophages isolated from arthroplasty tissues can differentiate into osteoclasts.
• To explore the cellular mechanisms underlying bone resorption in aseptic loosening.

Main Methods:

• Macrophages were isolated from human hip arthroplasty tissues and co-cultured with osteoblast-like cells.
• Cells were cultured with or without 1,25 dihydroxyvitamin D3 [1,25(OH)2D3] and macrophage colony-stimulating factor (M-CSF).
• Osteoclast differentiation and bone resorption activity were assessed using phenotypic markers and resorption assays.

Main Results:

• Macrophages from arthroplasty tissues expressed macrophage markers but not osteoclast markers initially.
• Upon co-culture with osteoblast-like cells and 1,25(OH)2D3, macrophages differentiated into multinucleated cells with osteoclast characteristics, including bone resorption.
• This differentiation was significantly reduced by M-CSF inhibition, and exogenous M-CSF was not required for differentiation.

Conclusions:

• Human macrophages from periprosthetic tissues can differentiate into functional osteoclasts.
• This differentiation process is independent of exogenous M-CSF, distinguishing them from other macrophage populations.
• Macrophage-osteoclast differentiation is a potential cellular mechanism driving osteolysis in aseptic loosening of arthroplasties.